Biotech, Batteries & BioSilk—Bold Breakouts

October 15, 2025

DENVER, Colo., Oct 15, 2025 (247marketnews.com)- As markets drift toward the close, the spotlight shifts from big tech to biotech, cleantech, and biomaterials. From genetically enhanced silkworms to AI-powered cancer therapies and decentralized battery networks, today’s session is a showcase of speculative strength and next-gen innovation. Here’s your Power Hour watchlist, the movers, the stories, and the setups traders are tracking into afterhours.

Kraig Biocraft Laboratories (OTCQB:KBLB) is turning heads again after the debut of BAM 1 Alpha, its latest genetically modified spider silk silkworm hybrid. Boasting 245% improved hybrid vigor and a 22% increase in cocoon shell weight, the tech could bring spider silk out of the lab and into defense, medical, and commercial textile markets. With scalability and throughput in focus, the stock is buzzing in biotech and defense chatter alike.

Genprex (NASDAQ:GNPX) collaborators will present positive preclinical data for Reqorsa Gene Therapy in ALK-positive non-small cell lung cancer at the major AACR-NCI-EORTC oncology conference next week. CEO Ryan Confer says the data “further validate REQORSA,” especially for younger, non-smoking patients with limited treatment options. With a presentation scheduled for October 25, traders are eyeing the setup ahead of biotech’s biggest fall stage.

Dragonfly Energy (NASDAQ:DFLI) is lighting up the energy space after securing a U.S. patent for its Dragonfly IntelLigence wireless mesh battery communication tech. This network lets battery systems share diagnostics, even when offline, ushering in a smarter, more adaptive energy infrastructure. CEO Dr. Denis Phares called it “a major step forward” in building an intelligent U.S.-made energy grid. With lithium names heating up again, this is one to watch into earnings season.

Small-Cap Speculation Watch: Biotech to BioFuel

  • Vivakor (NASDAQ:VIVK) is hovering on radar after recent updates to its oil remediation and heavy oil extraction tech. The company’s Utah operations may benefit from rising domestic energy chatter heading into Q4.
  • Theriva Biologics (NYSE:TOVA) is holding gains following pipeline updates tied to its microbiome-based therapies. With low float and an upcoming data catalyst, it’s on biotech traders’ shortlist.
  • Sana Biotechnology (NASDAQ:SANA), known for its work in in vivo gene delivery, is drawing volume spikes amid renewed M&A speculation in the gene editing space.
  • Absci (NASDAQ:ABSI) is rebounding after a tough quarter, with traders betting its generative AI platform for biologic drug discovery could see increased pharma interest.
  • Innovation Beverage Group (NASDAQ:IBG) is adding fizz with chatter around upcoming product launches in the functional and non-alcoholic beverage space. It’s been volatile, but remains a cult microcap among retail traders.

Ag & Food Innovation: From Seed to Shelf

  • Origin Agritech (NASDAQ:SEED) is rising after a strong dealer showcase in Northeast China and a new strategic partnership with Fengtian Seed Industry. CEO Weibin Yan said their regional re-entry is “pivotal,” and analysts are now modeling a much stronger FY26 sales outlook.
  • Australian Oilseeds Holdings (NASDAQ:COOT) is seeing renewed interest amid commodity strength and global canola supply concerns. As a vertically integrated processor, it’s positioned to benefit from oilseed margin expansion.
  • Pinnacle Food (NASDAQ:PINL) is on watch after a key distribution agreement in Asia. As the company pushes deeper into high-protein snack categories, Q4 growth could accelerate.
  • Arcadia Biosciences (NASDAQ:RKDA) is trying to bounce after a rough month. While fundamentals remain under scrutiny, recent news around stress-resistant crop IP has sparked speculative interest.
  • Above Food Ingredients (NASDAQ:ABVE) is steadily building on the plant-based proteins theme, with institutional investors starting to accumulate on U.S. expansion plans.
  • Bioceres Crop Solutions (NASDAQ:BIOX) is getting love from ESG investors after reaffirming guidance and highlighting advances in HB4 wheat and regenerative ag solutions.

For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com

Please click here to read the full Kraig Labs analyst report on 247marketnews.com.

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (KBLB, VIVK, GNPX, SANA, COOT, TOVA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.